AnaCardio
Pharmaceutical Manufacturing
Se
23 employees
- Employees
- 23
- Contacts
- 2
- Emails
- 2
- Phones
- 1
AnaCardio Overview
- Headquarters
- Se
- Website
- www.anacardio.com
- Industry
- Pharmaceutical Manufacturing
- Employees
- 23
- Funding
- 18.4M
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation Manufacturing
Keywords
About AnaCardio
AnaCardio AB is a privately held Swedish, clinical stage biopharmaceutical company developing novel drugs to treat heart failure. AnaCardio was founded based on ground-breaking research from Karolinska Institutet showing improved contractility of the heart muscle through a unique and differentiated mechanism. Its lead program AC01 is planned to enter phase 2 clinical development in heart failure patients in 2022. You can find more information about AnaCardio at www.anacardio.com.
AnaCardio Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
- Phone contacts
- 1
- 25.0% coverage
AnaCardio Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Mark Quick | Northwich, England, United Kingdom |
Email
|
|
| Jørgen Søberg Petersen | Senior Partner, Novo Holdings |
View
|
|
| Johan Dighed | Stockholm County, Sweden |
Email
Phone
|
|
| Fredrik Lehmann | Life Science Professional |
View
|
Compare Similar Companies to AnaCardio
Mynt
Financial Services
Quartr
Financial Services
Insurely
Financial Services
Evroc
Technology, Information And Internet
Moleculent
Biotechnology Research
Verdiva Bio
Biotechnology Research
Coave Therapeutics
Biotechnology Research
QA.tech
Software Development
Buddywise
Software Development
Telness
Telecommunications